33
Participants
Start Date
November 7, 2008
Primary Completion Date
August 31, 2010
Study Completion Date
November 30, 2010
VTX-2337
Escalating doses of the investigational drug will be administered to cohorts of patients until the highest tolerated dose is identified.
Mayo Clinic, Scottsdale
Scottsdale Healthcare, Scottsdale
Lead Sponsor
Celgene
INDUSTRY